Getting your Trinity Audio player ready... By Jef Feeley and Janan Hanna, Bloomberg News AbbVie was ordered to pay $150 million to an Oregon man who accused the drugmaker of hiding the heart-attack ...
(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug ...
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 ...
A federal jury on Monday ordered AbbVie to pay $3.2 million to an Oregon man who claims the testosterone replacement drug AndroGel caused him to suffer a heart attack, a far smaller penalty than the ...
The Federal Trade Commission won't let go of its pay-for-delay suit against AbbVie ($ABBV). The U.S. agency urged a Pennsylvania federal court to move forward with ...
AbbVie ($ABBV) escaped the wrath of the FTC in a pay-for-delay suit over AndroGel generics, as a federal judge who previously threw out antitrust claims against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback